Late last year, the Federal Government announced
an additional investment of $100 million to expand free
access to glucose-monitoring technology through the NDSS. This
initiative, comes into effect on 1 March 2019, and will see fully
subsidised CGM products expanded to include the following
- children and young people with conditions very similar to type
1 diabetes who require insulin;
- women with type 1 diabetes who are pregnant, post-pregnancy or
actively planning pregnancy; and
- people with type 1 diabetes aged 21 years or older who have
concessional status, and have a high clinical need to access CGM
The Government already provides access to subsidised CGM
products for children and young people with type 1 diabetes, under
21 years of age. The additional funding means from 1 March a
further 37,000 Australians will have access to CGM technology.
While this will improve the lives and give peace of mind to
thousands of Australians with type 1 diabetes, Diabetes Queensland
together with Diabetes Australia, our state affiliated bodies and
partners in the diabetes community will continue to advocate for
greater access to CGM for the broader diabetes community.
Check your eligibility
To access subsidised CGM products through the NDSS, you will
need to be assessed by an authorised health professional which
could include an endocrinologist, credentialed diabetes educator,
medical doctor, paediatrician or nurse practitioner to determine
whether you are eligible and to ensure that the use of CGM will
help as part of your diabetes management.
More information about the eligibility criteria for each group
eligible for subsided products can be found on the NDSS website.
Click on relevant link below to be taken to this important
If you have additional questions about your eligibility please
call the NDSS Helpline on 1300 136